Blood-Based Biomarkers Are Advancing Alzheimer’s Testing
Blood-based biomarker tests are revolutionizing Alzheimer's diagnostic testing and management of Alzheimer’s disease.
Category: Dementias & Alzheimer’s
Dementias & Alzheimer’s
Latest
Dementias & Alzheimer’s
Latest
Parkinson’s Disease Needs Improved Diagnostic Processes
A study found that up to 17.7% of initial Parkinson’s disease diagnoses are later revised, highlighting the challenges of its diagnosis.
Dementias & Alzheimer’s
Latest
P-tau not as Disease-Specific for Alzheimer’s as Previously Thought
The detection of p-tau proteins in the blood for early Alzheimer’s disease (AD) diagnosis is less specific than previously believed.
FDA Grants Breakthrough Device Designation for Beckman Coulter Alzheimer’s Blood Test
The FDA granted Breakthrough Device Designation to Beckman Coulter’s Access p-Tau217/β-Amyloid 1-42 plasma ratio blood test.
Read More
New Biomarker Tests Enable Early Diagnosis of Synucleinopathies
A new expert-led paper highlights the potential of biomarker testing to improve early diagnosis and treatment of synucleinopathies.
Read More
New Guidelines Developed to Diagnose Common Memory Disorder Mistaken for Alzheimer’s
New guidelines for limbic-predominant age-related TDP-43 encephalopathy aim to differentiate the memory-loss syndrome from Alzheimer’s.
Read More
New Blood Biomarkers Could Transform Alzheimer’s Diagnosis
Declining blood levels of acetyl-L-carnitine and free carnitine are closely linked to Alzheimer’s severity, with sex-specific differences.
Read More
Breakthrough Device Designation Granted to pTau 217 Blood Test for Alzheimer’s Detection
Spear Bio’s pTau 217 blood test, a less-invasive solution for early Alzheimer’s diagnosis, received an FDA Breakthrough Device Designation.
Read More
Structure of Huntington’s Disease Protein Clumps Identified
Researchers have visualized the atomic-level structure of protein clumps linked to Huntington’s disease, paving the way for diagnostic tools.
Read More
Alpha-Synuclein: Adding Precision to Neurodegenerative Testing
This episode of Clinical Lab Chat covers the how and why of making precise clinical diagnosis of neurodegenerative diseases.
Read More
Universities Collaborate on Validating Blood Test for Early Alzheimer’s Detection
Two universities are conducting a validation study on a blood test designed to detect early neurodegeneration in Alzheimer’s disease.
Read More
How a Skin Biopsy Can Evaluate Synucleinopathies
A new study demonstrates the clinical utility of a skin biopsy diagnostic tool in improving care for those with neurodegenerative diseases.
Read More
New Blood Test Biomarker Could Detect Dementia Risk Earlier and More Cost-Effectively
Researchers identified a promising blood biomarker for detecting vascular contributions to cognitive impairment and dementia.
Read More
Preparing Your Lab for Blood-Based Alzheimer’s Disease Testing
Blood-based diagnostics for Alzheimer’s disease and other neurological conditions could be here sooner than you think.
Read More
Researchers Explore Reliable Ways to Diagnose Alzheimer’s
Researchers explored how combining CSF analysis and amyloid PET imaging can improve the accuracy and efficiency of Alzheimer’s diagnosis.
Read More
VeraBIND Tau Assay for Alzheimer’s Detection Gets Positive Study Feedback
Study results were revealed for the VeraBIND Tau assay diagnostic test designed to detect active Alzheimer’s disease pathology.
Read More
Finger-Prick Blood Test Could Revolutionize Alzheimer’s Detection
A new capillary blood test offers a simple, mail-in method to detect Alzheimer’s biomarkers, paving the way for accessible global testing.
Read More
Blood Test Detects Parkinson’s Disease Through Alpha Synuclein Biomarkers
Sunbird Bio demonstrated that its blood-based alpha synuclein biomarkers can accurately detect Parkinson’s disease.
Read More